Clinical pharmacokinetics in the causal treatment of acute intoxications
Lesne, M.; Jacqmin, P.; Bouchat, J.M.; Mahieu, P.
Therapie 36(5): 511-523
1981
ISSN/ISBN: 0040-5957 PMID: 7034287 Document Number: 175078
Document emailed within 1 workday
Related Documents
Wattel, F.; Chopin, C.; Durocher, A.; Berzin, B. 1978: Rhabdomyolysis in acute intoxications La Nouvelle Presse Medicale 7(29): 2553-2554; 2559-2560Köhler, H. 1971: Therapy of acute intoxications Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 26(14): 180-182
Cornette, M.; Noirfalise, A.; Franck, G. 1971: Diagnosis of acute drug-induced intoxications Revue Medicale de Liege 26(4): 124-127
Sangster, B.; Meulenbelt, J. 1988: Acute pulmonary intoxications. Overview and practical guidelines Netherlands Journal of Medicine 33(1-2): 91-100
de Groot, G.; Maes, R.A.; van Heyst, A.N. 1977: The use of haemoperfusion in the elimination of absorbed drug mixtures in acute intoxications Netherlands Journal of Medicine 20(4-5): 142-148
Goleva, O.P.; Sabaev, A.V. 2009: The medical social aspects of acute intoxications of chemical etiology Problemy Sotsial'noi Gigieny Zdravookhraneniia i Istorii Meditsiny 6: 27-29
Tempe, J.D.; Jaeger, A.; Beissel, J.; Burg, F.; Mantz, J.M. 1976: Acute intoxications due to cardiotropic drugs : ajmaline, chloroquine and digitalin Minerva Medica 67(61): 4035-4044
Sabaev, A.V.; Goleva, O.P. 2012: The dynamics of population mortality due to acute alcoholic intoxications in the Russian Federation Problemy Sotsial'noi Gigieny Zdravookhraneniia i Istorii Meditsiny 4: 21-23
Bouletreau, P.; Meunier, J.; Kérihuel, J.C.; Ritter, W. 1985: Clinical study of muzolimine in acute renal failure, pharmacodynamics and pharmacokinetics Zeitschrift für Kardiologie 74(Suppl 2): 96-99
Daniel, W.; Syrek, M.; Janczar, L.; Boksa, J. 1995: The pharmacokinetics of promazine and its metabolites after acute and chronic administration to rats--a comparison with the pharmacokinetics of imipramine Polish Journal of Pharmacology 47(2): 127-136
Petterino, C.; Paolo, B.; Tristo, G. 2004: Clinical and pathological features of anticoagulant rodenticide intoxications in dogs Veterinary and Human Toxicology 46(2): 70-75
Ni, J.; Chen, G.; Shen, Z.; Li, X.; Liu, H.; Huang, Y.; Fang, Z.; Chen, S.; Wang, Z.; Chen, Z. 1998: Pharmacokinetics of intravenous arsenic trioxide in the treatment of acute promyelocytic leukemia Chinese Medical Journal 111(12): 1107-1110
Paxton, J.W. 1981: Elementary pharmacokinetics in clinical practice 4: genetic, environmental and age influences on pharmacokinetics New Zealand Medical Journal 94(697): 423-425
Van der Kleijn, E.; Baars, A.M.; Vree, T.B.; van der Dries, A. 1983: Clinical pharmacokinetics of drugs used in the treatment of status epilepticus Advances in Neurology 34: 421-440
Aubry, J.P.; Charpentier, G.; Jaillon, P.; Thomas, M.; Duron, F.; Richard, M.O.; Cheymol, G. 1983: Pharmacokinetics of lithium in hyperthyroid patients. Comparison of results before and after treatment of the acute phase of hyperthyroidism Therapie 38(1): 39-46
Chen, G.Q.; Shen, Z.X.; Wu, F.; Han, J.Y.; Miao, J.M.; Zhong, H.J.; Li, X.S.; Zhao, J.Q.; Zhu, J.; Fang, Z.W.; Chen, S.J.; Chen, Z.; Wang, Z.Y. 1996: Pharmacokinetics and efficacy of low-dose all-trans retinoic acid in the treatment of acute promyelocytic leukemia Leukemia 10(5): 825-828
Muchi, H.; Ijima, H.; Karube, T. 1985: The treatment of childhood acute lymphoblastic leukemia based on the pharmacokinetics of methotrexate in serum and cerebrospinal fluid Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 48(6): 1397-1408
Hajnovic, L.; Knöller, S.; Schütz, L. 2018: Causal Relation of Psychical Stress to Acute Back Pain Acta Chirurgiae Orthopaedicae et Traumatologiae Cechoslovaca 85(3): 216-218
Feldt, T.; Oette, M.; Kroidl, A.; Göbels, K.; Leidel, R.; Sagir, A.; Kuschak, D.; Häussinger, D. 2005: Atazanavir for treatment of HIV infection in clinical routine: efficacy, pharmacokinetics and safety European Journal of Medical Research 10(1): 7-10
Kuca, K.; Jun, D.; Bajgar, J. 2007: Structural factors influencing potency of currently used acetylcholinesterase reactivators for treatment of cyclosarin intoxications Current Pharmaceutical Design 13(33): 3445-3452